Despoina Pantazi

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Journal of cardiovascular development and disease

Pharmaceuticals (Basel, Switzerland)

BioFactors (Oxford, England)

Drug design, development and therapy

University of Ioannina

University of Ioannina (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Ioannina

Greece

Dr :: Chemistry

Education History

University of Ioannina

Greece

PHD

University Of Ioannina

Greece

MSC :: Chemistry

Publications

Petros Spyridonas Adamidis, Despoina Pantazi, Iraklis C Moschonas, Evangelos N Liberopoulos, Alexandros D Tselepis
Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect? Journal of cardiovascular development and disease 11 (3) (2024)
Louisa Pechlivani, Nikoleta Ntemou, Despoina Pantazi, Dimitrios Alivertis, Konstantinos Skobridis, Alexandros D Tselepis
Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Petros Spyridonas Adamidis, Despoina Pantazi, Iraklis C Moschonas, Evangelos N Liberopoulos, Alexandros D Tselepis
Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect? Journal of cardiovascular development and disease 11 (3) (2024)
Louisa Pechlivani, Nikoleta Ntemou, Despoina Pantazi, Dimitrios Alivertis, Konstantinos Skobridis, Alexandros D Tselepis
Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Petros Spyridonas Adamidis, Despoina Pantazi, Iraklis C Moschonas, Evangelos N Liberopoulos, Alexandros D Tselepis
Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect? Journal of cardiovascular development and disease 11 (3) (2024)
Louisa Pechlivani, Nikoleta Ntemou, Despoina Pantazi, Dimitrios Alivertis, Konstantinos Skobridis, Alexandros D Tselepis
Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Despoina Pantazi, Constantinos Tellis, Alexandros D Tselepis
"SI: PAF" Oxidized phospholipids and lipoprotein-associated phospholipase A 2 (Lp-PLA 2 ) in atherosclerotic cardiovascular disease: An update. BioFactors (Oxford, England) (2022)
Sofia Sidiropoulou, Styliani Papadaki, Aikaterini N Tsouka, Ioannis K Koutsaliaris, Vasileios G Chantzichristos, Despoina Pantazi, Minas E Paschopoulos, Kenny M Hansson, Alexandros D Tselepis
The Effect of Platelet-Rich Plasma on Endothelial Progenitor Cell Functionality. Angiology 72 (8) (2021)
Despoina Pantazi, Nikoleta Ntemou, Alexios Brentas, Dimitrios Alivertis, Konstantinos Skobridis, Alexandros D Tselepis
Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and Nilotinib. Drug design, development and therapy 13 (2019)

Despoina Pantazi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Despoina Pantazi